Skip to main navigation Skip to search Skip to main content

Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease

  • ECCO CONFER Investigators
  • Department of Internal Medicine and Hepato-gastroenterology Unit, Notre-Dame de Grâce Hospital, Gosselies, Belgium [email protected].
  • Department of Neurology, Université Catholique de Louvain, Yvoir, Belgium.
  • Department of Gastroenterology, Université Catholique de Louvain, St-Luc Hospital, Brussels, Belgium.
  • Darlington Memorial and Bishop Auckland Hospitals, County Durham and Darlington NHS Foundation Trust, Durham, UK.
  • Department of Gastroenterology, Kloof Hospital, Pretoria, South Africa.
  • Department of Gastroenterology, Shaare-Zedek Medical Center, Jerusalem, Israel.
  • Department of Gastroenterology, Hospital Israelita Albert Einstein, Sao Paolo, Brazil.
  • Department of Gastroenterology, University Hospital Zvezdara, Belgrade, Serbia.
  • Department of Internal Medicine and Medical Therapy University of Messina, Messina, Italy.
  • Scientific Support Unit, Université Catholique de Louvain, Yvoir, Belgium.
  • Department of Gastroenterology, Université Catholique de Louvain, Yvoir, Belgium.
  • Division of Gastroenterology, University Hospital of Ioannina, Ioannina, Greece.

Research output: Contribution to journalArticleAcademicpeer-review

15 Downloads (Pure)

Abstract

BACKGROUND AND AIMS: Acute optic neuritis [ON] is an inflammatory condition affecting the optic nerve. Clinicians should suspect optic neuritis in cases of painful and rapidly progressive loss of central visual field. This condition may be associated with a multitude of diseases, and mostly with multiple sclerosis [MS] where it may present as an initial symptom. The literature reports that optic neuritis and MS occur in patients with inflammatory bowel disease [IBD] before and after the era of anti-tumour necrosis factor-α [TNFα] drugs. At the present moment, there is little consensus for managing this complication, currently treated with corticosteroids and discontinuation of the causative agents.

METHODS: We collected cases through a retrospective multicentre European Crohn's and Colitis Organisation CONFER [COllaborative Network For Exceptionally Rare case reports] project. We also performed a comprehensive retrospective search of the available literature on this topic.

RESULTS: We report herein 12 new cases of ON, including 10 under anti-TNF therapy, collected through the CONFER project. We also compare characteristics of ON associated or not with anti-TNFα agents.

CONCLUSIONS: The exceptional and current observation of distant family history of MS in 17% of our patients who developed ON, despite the small number and the lack of a control arm, might be an important signal that should be taken into account in our therapeutic strategies in the future.

Original languageEnglish
Pages (from-to)541-8
Number of pages8
JournalJournal of Crohn's and Colitis
Volume10
Issue number5
DOIs
Publication statusPublished - 2016

Keywords

  • Journal Article

Fingerprint

Dive into the research topics of 'Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease'. Together they form a unique fingerprint.

Cite this